Cost-effectiveness of six strategies for Helicobacter pyloridiagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern

被引:0
|
作者
Kyland P Holmes
John C Fang
Brian R Jackson
机构
[1] ARUP Laboratories,Department of Medicine
[2] University of Utah,Department of Pathology
[3] University of Utah,undefined
关键词
Proton Pump Inhibitor; Pylorus Infection; Dyspepsia; Triple Therapy; Proton Pump Inhibitor Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 17 条
  • [1] Cost-effectiveness of six strategies for Helicobacter pylori diagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern
    Holmes, Kyland P.
    Fang, John C.
    Jackson, Brian R.
    [J]. BMC HEALTH SERVICES RESEARCH, 2010, 10
  • [2] Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia
    Ford, Alexander C.
    Howden, Colin W.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (11) : 2986 - 2987
  • [3] Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia Reply
    Wechsler, Emily V.
    Chan, Walter
    Shah, Eric D.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (11) : 2987 - 2988
  • [4] Cost-effectiveness analysis of two management strategies for dyspepsia
    Kjeldsen, Hans C.
    Bech, Mickael
    Christensen, Bo
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (03) : 376 - 384
  • [5] Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia
    Groeneveld, PW
    Lieu, TA
    Fendrick, AM
    Hurley, LB
    Ackerson, LM
    Levin, TR
    Allison, JE
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (02): : 338 - 347
  • [6] The cost-effectiveness of alternative strategies in the management of patients with uninvestigated dyspepsia (UD): Comparing the CanDys approach to empirical antisecretory therapy and prompt endoscopy
    Barkun, A
    Crott, R
    Fallone, CA
    Kennedy, WA
    Lachaine, J
    Levinton, C
    Armstrong, D
    Chiba, N
    Thomson, ABR
    Van Zanten, VSJO
    Sinclair, P
    Chakraborty, B
    Escobedo, S
    Smyth, S
    White, RE
    Nevin, K
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 246 - 247
  • [7] The cost-effectiveness of alternative strategies in the management of patients with uninvestigated dyspepsia: The CanDys approach using ranitidine versus omeprazole as anti-secretory medication.
    Barkun, A
    Crott, R
    Fallone, C
    Kennedy, W
    Lachaine, J
    Levinton, C
    Armstrong, D
    Chiba, N
    Thomson, A
    Van Zanten, SJO
    Sinclair, P
    Chakraborty, B
    Escobedo, S
    Smyth, S
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A465 - A465
  • [8] The cost-effectiveness of alternative strategies in the short term management of patients with uninvestigated dyspepsia: The CanDys approach versus empiric anti-secretory therapy using omeprazole.
    Barkun, A
    Crott, R
    Fallone, C
    Kennedy, W
    Lachaine, J
    Levinton, C
    Armstrong, D
    Chiba, N
    Thomson, ABR
    Van Zanten, SJO
    Sinclair, P
    Chakraborty, B
    Escobedo, S
    Smyth, S
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A474 - A474
  • [9] The cost-effectiveness of treating Helicobacter pylori (Hp) negative primary care patients with uninvestigated dyspepsia (UD) using omeprazole, ranitidine, cisapride or placebo.
    van Zanten, SV
    Chiba, N
    Armstrong, D
    Barkun, AN
    Thomson, ABR
    Grace, E
    Ahmad, F
    Smyth, S
    Sinclair, P
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A19 - A19
  • [10] Comparison of two management strategies for Helicobacter pylori treatment: Clinical study and cost-effectiveness analysis
    Marko, D
    Calvet, X
    Ducons, J
    Guardiola, J
    Tito, L
    Bory, F
    [J]. HELICOBACTER, 2005, 10 (01) : 22 - 32